These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 2360879)

  • 1. Warfarin antagonism of natto and increase in serum vitamin K by intake of natto.
    Kudo T
    Artery; 1990; 17(4):189-201. PubMed ID: 2360879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Warfarin therapy and chlorella].
    Ohkawa S; Yoneda Y; Ohsumi Y; Tabuchi M
    Rinsho Shinkeigaku; 1995 Jul; 35(7):806-7. PubMed ID: 8777808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-dose oral vitamin K reliably reverses over-anticoagulation due to warfarin.
    Crowther MA; Donovan D; Harrison L; McGinnis J; Ginsberg J
    Thromb Haemost; 1998 Jun; 79(6):1116-8. PubMed ID: 9657434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of warfarin at beginning doses on patients with valve replacement.
    Kudo T; Hashimoto M; Uchino T; Osada T; Furukawa K
    Artery; 1992; 19(6):344-52. PubMed ID: 1471923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of natto, a fermented soybean preparation, to prevent excessive plasma vitamin K concentrations in patients taking warfarin.
    Homma K; Wakana N; Suzuki Y; Nukui M; Daimatsu T; Tanaka E; Tanaka K; Koga Y; Nakajima Y; Nakazawa H
    J Nutr Sci Vitaminol (Tokyo); 2006 Oct; 52(5):297-301. PubMed ID: 17190098
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intake of fermented soybean (natto) increases circulating vitamin K2 (menaquinone-7) and gamma-carboxylated osteocalcin concentration in normal individuals.
    Tsukamoto Y; Ichise H; Kakuda H; Yamaguchi M
    J Bone Miner Metab; 2000; 18(4):216-22. PubMed ID: 10874601
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vitamin K intake and sensitivity to warfarin in patients consuming regular diets.
    Lubetsky A; Dekel-Stern E; Chetrit A; Lubin F; Halkin H
    Thromb Haemost; 1999 Mar; 81(3):396-9. PubMed ID: 10102468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The interaction between vitamin K nutriture and warfarin administration in patients with bacterial overgrowth due to atrophic gastritis.
    Camilo ME; Paiva SA; O'Brien ME; Booth SL; Davidson KW; Sokoll LJ; Sadowski JA; Russell RM
    J Nutr Health Aging; 1998; 2(2):73-8. PubMed ID: 10993569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antidotal effect of vitamin K1 against warfarin-induced anticoagulation in horses.
    Byars TD; Greene CE; Kemp DT
    Am J Vet Res; 1986 Oct; 47(10):2309-12. PubMed ID: 3777660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation.
    Kamali F; Edwards C; Butler TJ; Wynne HA
    Thromb Haemost; 2000 Jul; 84(1):39-42. PubMed ID: 10928467
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose vitamin K to augment anticoagulation control.
    Reese AM; Farnett LE; Lyons RM; Patel B; Morgan L; Bussey HI
    Pharmacotherapy; 2005 Dec; 25(12):1746-51. PubMed ID: 16305294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of diet on blood vitamin K status and urinary mineral excretion assessed by a food questionnaire.
    Sakamoto N; Nishiike T; Iguchi H; Sakamoto K
    Nutr Health; 1999; 13(1):1-10. PubMed ID: 10376274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of warfarin in the nephrotic syndrome and effect on vitamin K-dependent clotting factors.
    Ganeval D; Fischer AM; Barre J; Pertuiset N; Dautzenberg MD; Jungers P; Houin G
    Clin Nephrol; 1986 Feb; 25(2):75-80. PubMed ID: 3698349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Complications and risks associated with an anticoagulation therapy combining low molecular weight heparin and Warfarin after total replacement of large joints--our experience].
    Míka P; Behounek J; Skoták M; Nevsímal L
    Acta Chir Orthop Traumatol Cech; 2004; 71(4):237-44. PubMed ID: 15456102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimal dose of prothrombin complex concentrate for acute reversal of oral anticoagulation.
    Yasaka M; Sakata T; Naritomi H; Minematsu K
    Thromb Res; 2005; 115(6):455-9. PubMed ID: 15792675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. First Clinical Trial of a Newly Developed, Low Menaquinone-7, Fermented Soybean Natto in Warfarin-Dependent Patients.
    Nakajima T; Taya Y; Nishikawa T; Kitamura Y; Kato H; Mathis BJ; Hiramatsu Y
    J Med Food; 2021 Aug; 24(8):860-865. PubMed ID: 34406879
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the efficacy and safety profiles of intravenous vitamin K and fresh frozen plasma as treatment of warfarin-related over-anticoagulation in patients with mechanical heart valves.
    Yiu KH; Siu CW; Jim MH; Tse HF; Fan K; Chau MC; Chow WH
    Am J Cardiol; 2006 Feb; 97(3):409-11. PubMed ID: 16442406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poor correlation of supratherapeutic international normalised ratio and vitamin K-dependent procoagulant factor levels during warfarin therapy.
    Sarode R; Rawal A; Lee R; Shen YM; Frenkel EP
    Br J Haematol; 2006 Mar; 132(5):604-7. PubMed ID: 16445834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental research on the hyperprothrombinemic activity of an isocoumarin derivative: antagonism against anticoagulant dicoumarol (Warfarin)].
    Reina RA
    Farmaco Sci; 1975 Dec; 30(12):947-54. PubMed ID: 1204832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.